STUDIES OF HEMOLYTIC ANEMIA
溶血性贫血的研究
基本信息
- 批准号:3341066
- 负责人:
- 金额:$ 15.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-07-01 至 1993-04-30
- 项目状态:已结题
- 来源:
- 关键词:aniline ankyrins blood toxicology cell senescence covalent bond dapsone dosage drug adverse effect drug design /synthesis /production drug metabolism erythrocytes free radical oxygen glucose 6 phosphate dehydrogenase deficiency hemolysis hemolytic anemia hemotoxin high performance liquid chromatography laboratory rat membrane lipids membrane proteins methemoglobin oxidation primaquine radiation detector radiotracer scintillation spectrometry spectrin spectrometry stainings stoichiometry thin layer chromatography toxicant interaction toxin metabolism
项目摘要
A profound hemolytic anemia following exposure to arylamine
drugs and environmental chemicals affects Americans of African
and Mediterranean descent (Italian, Greek, etc.). In the 50's and
60's, extensive studies on primaquine and phenylhydrazine led to
the concept that (re) active metabolites of the drugs damaged red
cells by "oxidative stress". The hemotoxic metabolites however
were not identified and the postulate of "oxidative stress" as the
mechanism underlying drug-induced hemolytic anemia was not
further developed. We have now identified hemolytic metabolites
of aniline, dapsone and phenacetin and observed high hemolytic
activity with a putative metabolite of primaquine. Mechanism
studies using the hemolytic metabolite of depsone (DDS-NOH) in
rat red cells indicated that DDS-NOH causes a), formation of
disulfide-linked adducts between certain membrane skeletal
proteins and hemoglobin monomers, and b), development of an
extreme echinocyte morphology. These data, taken together with
recent literature observations on acitive oxygen biochemistry, red
cell skeletal protein function, and the normal mechanisms of
splenic sequestration of "old" red cells, suggest an overall working
hypothesis for the mechanism of drug-induced hemolytic anemia;
viz that the toxic drug metabolites interact with oxyhemoglobin
to generate oxygen free radicals, which in turn generate free
radicals of hemoglobin sulfhydryl groups. Adduct formation
between hemoglobin and membrane skeletal proteins results in
loss of stuctural integrity and activation of senescent antibody
binding sites on the cell surface, with subsequent macrophage
phagocytosis. The objectives of the present studies are a), to
indentify the hemolytic metobolites of primaquine, b) to define
the role of acitve oxygen species in activating red cell protein
sulfhydryl groups and in the commitment of DDS-NOH damaged
red cells to splenic sequestration, c) to identify the domains of
spectrin andd ankyrin to which the hemoglobin monomers bind and
to assess the structural significance of this binding, and d), to
determine whether or not the senescent antibody plays a role in
the removal of DDS-NOH damaged red cells from the circulation.
It is expected that these studies will determine the relative
importance of N vs C oxidation products of primaquine in
primaquine hemotoxicity, establish whether or not active oxygen
species are obligatory in the hemolytic sequence, and provide a
firm basis for more detailed resolution of how skeletal protein
structure on the inside of the red cell membrane determines the
properties and structures of the outer surface of the red cell.
暴露于芳胺后发生严重溶血性贫血
毒品和环境化学物质影响着非洲的美国人,
和地中海血统(意大利,希腊等)。 在50年代和
60年代,伯氨喹和苯肼的广泛研究导致
药物的活性代谢物破坏红细胞的概念
细胞的“氧化应激”。 然而,
没有被确定,“氧化应激”的假设是
药物诱导的溶血性贫血的潜在机制不是
进一步发展。 我们已经鉴定出溶血代谢物
苯胺,氨苯砜和非那西丁,并观察到高溶血性
与伯氨喹的推定代谢物的活性。 机制
使用Depsone的溶血代谢物(DDS-NOH)的研究
大鼠红细胞表明,DDS-NOH导致a),形成
某些膜骨架之间的二硫键连接的加合物
蛋白质和血红蛋白单体,和B),
极端的棘细胞形态。 这些数据与
活性氧生物化学的最新文献观察
细胞骨架蛋白功能,以及
脾隔离的“老”红细胞,表明一个整体的工作
药物性溶血性贫血机制假说;
即毒性药物代谢物与氧合血红蛋白相互作用
产生氧自由基,这反过来又产生自由基,
血红蛋白巯基的自由基。 加合物形成
血红蛋白和膜骨架蛋白之间的联系
结构完整性丧失和衰老抗体活化
细胞表面的结合位点,随后巨噬细胞
吞噬作用 本研究的目标是:(a)
鉴定伯氨喹的溶血代谢物,B)确定
活性氧在活化红细胞蛋白中作用
巯基和在DDS-NOH的承诺受损
红细胞脾隔离,c)以确定
血影蛋白和锚蛋白,血红蛋白单体与之结合,
评估这种结合的结构意义,和d),
确定衰老抗体是否在
DDS-NOH从循环中去除受损的红细胞。
预计这些研究将确定相对
伯氨喹的N与C氧化产物在
伯氨喹血液毒性,确定是否有活性氧
种在溶血序列中是必须的,并提供了一个
为更详细地解决骨骼蛋白质
红细胞膜内部的结构决定了
红细胞外表面的性质和结构。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID J. JOLLOW其他文献
DAVID J. JOLLOW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID J. JOLLOW', 18)}}的其他基金
相似海外基金
UNDERSTANDING THE INTERACTION OF ANKYRINS AND NANOMATERIALS
了解锚蛋白和纳米材料的相互作用
- 批准号:
8403578 - 财政年份:2007
- 资助金额:
$ 15.28万 - 项目类别:
UNDERSTANDING THE INTERACTION OF ANKYRINS AND NANOMATERIALS
了解锚蛋白和纳米材料的相互作用
- 批准号:
8601532 - 财政年份:2007
- 资助金额:
$ 15.28万 - 项目类别:
UNDERSTANDING THE INTERACTION OF ANKYRINS AND NANOMATERIALS
了解锚蛋白和纳米材料的相互作用
- 批准号:
8214426 - 财政年份:2007
- 资助金额:
$ 15.28万 - 项目类别: